Answers are grounded in this paper and cite their sources.
Patients with SSc and anti-RNPC-3 antibodies are more likely to be male and African American and to have moderate-to-severe GI disease and ILD. Further studies on larger patient cohorts may be helpful in further defining subsets of patients with SSc at risk for severe GI involvement.
No takes yet. Share an insight, caveat, or question.
McMahan et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: